Canada markets close in 1 hour 30 minutes

Kuros Biosciences AG (CSBTF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
7.50+0.40 (+5.63%)
As of 11:01AM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 270.34M
Enterprise Value 257.46M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)7.09
Price/Book (mrq)4.23
Enterprise Value/Revenue 7.67
Enterprise Value/EBITDA -24.73

Trading Information

Stock Price History

Beta (5Y Monthly) 0.91
52-Week Change 3275.66%
S&P500 52-Week Change 322.38%
52 Week High 39.05
52 Week Low 31.89
50-Day Moving Average 36.94
200-Day Moving Average 34.37

Share Statistics

Avg Vol (3 month) 31.28k
Avg Vol (10 day) 3375
Shares Outstanding 536.88M
Implied Shares Outstanding 638.08M
Float 824.55M
% Held by Insiders 135.24%
% Held by Institutions 17.27%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:100
Last Split Date 3Jun 23, 2016

Financial Highlights

Currency in CHF.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -40.90%
Operating Margin (ttm)-19.94%

Management Effectiveness

Return on Assets (ttm)-7.01%
Return on Equity (ttm)-21.86%

Income Statement

Revenue (ttm)33.56M
Revenue Per Share (ttm)0.92
Quarterly Revenue Growth (yoy)173.80%
Gross Profit (ttm)N/A
EBITDA -6.56M
Net Income Avi to Common (ttm)-13.73M
Diluted EPS (ttm)-0.41
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)14.21M
Total Cash Per Share (mrq)0.39
Total Debt (mrq)2.21M
Total Debt/Equity (mrq)3.90%
Current Ratio (mrq)2.06
Book Value Per Share (mrq)1.54

Cash Flow Statement

Operating Cash Flow (ttm)-8.84M
Levered Free Cash Flow (ttm)-7.29M